5.6.2024: Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver it to target cells. Hongjian Wang and colleagues at Wuhan University, China, present these findings in the open-access journal PLOS Biology. Recent years have seen an explosion of research attempting to harness CRISPR gene-editing systems.
7.12.2015: Currently, we solve three main tasks using Arabidopsis thaliana as model: 1. Genetic determination of metabolome pathway connected to prenylflavonoid and lupulin production in hop. 2. Study of...
14.3.2017: More than 400 decision makers and professionals attended PHARM Connect this year from over 25 countries with the same purpose: sharing their experiences, building new partnerships, finding the best...
3.5.2017: A Slovenian research institute developed protein patches applicable for healing chronic skin wounds rapidly and cost efficiently. Patches are biodegradable – disappearing in the wound, leaving no...
11.8.2014: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech industries, Pharma-Biotech Product and Company Valuation with Dr. Patrik Frei!
Having the status of the official portal for Czech biotechnology, Gate2Biotech serves to biotechnology companies, suppliers, investors, institutions, students and general public interested in biotechnology.
The portal is dedicated to the following subjects: plant and animal ...
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology Books - Huge database of biotechnology books
Biotechnology education - National biotechnology education centre
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants
DNA particles that mimic viruses hold promise as vaccines